program
ribosom
frameshift
prf
mechan
cisact
element
mrna
direct
elong
ribosom
shift
read
frame
base
direct
mani
rna
virus
util
prf
includ
retrovirus
coronavirus
flavivirus
totivirus
retrovirus
totivirus
open
read
frame
orf
encod
major
viral
nucleocapsid
protein
eg
gag
locat
mrna
wherea
orf
encod
protein
enzymat
function
typic
pro
pol
locat
frame
gag
orf
mrna
transcrib
viral
templat
contain
two
overlap
orf
enzymat
protein
translat
result
program
ribosom
frameshift
event
occur
effici
depend
specif
viru
assay
system
employ
thu
major
translat
event
result
product
gag
protein
minor
frameshift
yield
viral
enzymat
protein
ratio
gag
gagpol
synthes
virus
consequ
program
frameshift
vari
narrow
window
coronavirus
flavivirus
frameshift
event
occur
wider
dynam
rang
regul
rel
ratio
nonstructur
protein
import
maintain
precis
ratio
viral
protein
viru
propag
demonstr
retrovirus
coronavirus
flavivrius
two
endogen
virus
yeast
saccharomyc
cerevisia
start
yeast
killer
viru
extens
document
small
alter
program
frameshift
effici
promot
rapid
loss
yeast
dsrna
la
killer
viru
la
gagpol
dimer
nucleat
format
viru
particl
increas
amount
gagpol
protein
synthes
may
caus
mani
particl
initi
nonproduct
produc
littl
may
prevent
effici
dimer
similarli
increas
decreas
effici
ribosom
frameshift
retrotranspos
element
yeast
result
reduc
retrotransposit
frequenc
proteolyt
process
tyatyb
gagpol
equival
polyprotein
analog
gagpol
process
retrovirus
increas
amount
gagpol
protein
synthes
inhibit
proteolyt
process
polyprotein
consequ
format
matur
form
rnase
h
integras
revers
transcriptas
block
similarli
chang
ratio
gag
gagpol
protein
retrovirus
like
hiv
moloney
murin
leukemia
viru
interfer
virusparticl
format
case
overexpress
gagpol
protein
result
ineffici
process
polyprotein
inhibit
viru
product
although
product
produc
prf
differ
coronavirus
flavivirus
consequ
chang
prf
effici
similar
coronavirus
small
chang
prf
neg
impact
product
infecti
viru
japanes
enceph
flaviviru
chang
prf
import
neuroinvas
sum
viral
prf
effici
fine
tune
deliv
precis
ratio
protein
requir
effici
viral
particl
assembl
much
littl
frameshift
alter
ratio
detriment
consequ
base
studi
propos
prf
present
novel
target
prevent
viral
propag
end
develop
simpl
cost
effect
assay
system
would
hasten
identif
therapeut
agent
target
molecular
mechan
number
quantit
assay
employ
monitor
prf
cell
free
vitro
translat
assay
advantag
directli
monitor
product
format
provid
accur
readout
amount
molecular
weight
frameshift
product
howev
direct
product
monitor
present
numer
roadblock
highthroughput
screen
ht
applic
includ
requir
vitro
translat
system
radioact
label
rel
small
amount
product
requir
multipl
secondari
process
step
includ
sdspage
autoradiographi
andor
immunoprecipit
mass
spectrophotometr
method
highli
accur
also
problemat
reason
enzymat
assay
prefer
rout
perform
either
live
cell
cell
extract
requir
direct
monitor
frameshift
product
requir
use
radioact
materi
extens
handl
first
assay
employ
monocistron
report
system
confound
effect
report
mrna
stabil
produc
fals
posit
result
correct
develop
dualreport
construct
intern
control
effect
mrna
stabil
differ
rate
transcript
second
gener
system
util
lacz
andor
luciferas
report
enzym
pose
two
drawback
regard
util
highthroughput
screen
requir
numer
manipul
step
costeffect
recent
mammalian
cell
vivo
dualfluoresc
proteinbas
system
describ
enabl
rapid
accur
screen
compound
without
requir
laborintens
manipul
expens
reagent
howev
cost
associ
produc
maintain
report
cell
use
system
remain
prohibit
describ
develop
yeastbas
dualfluoresc
system
accur
detect
even
slight
chang
prf
caus
mutat
drug
singl
plate
assay
rapid
inexpens
amen
ht
applic
mata
ade
use
anisomycin
studi
wildtyp
yeast
strain
isogen
mutant
strain
base
contain
low
copi
plasmid
express
mutant
version
ribosom
protein
dual
fluoresc
plasmid
use
studi
base
high
copi
vector
transcript
direct
yeast
promot
monomer
dsred
orf
follow
egfp
orf
report
mrna
dsred
orf
follow
yeast
la
viru
deriv
prf
signal
turn
follow
egfp
orf
read
frame
rel
dsred
synthesi
egfp
protein
conting
upon
prf
event
except
one
nucleotid
insert
immedi
la
prf
signal
inactiv
prf
signal
place
egfp
orf
frame
dsred
use
control
similarli
harbor
type
prf
signal
egfp
frame
use
type
control
aka
use
empti
vector
control
yeast
cell
transform
empti
vector
plasmid
vector
without
fluoresc
proteincod
sequenc
frameshift
signal
control
report
plasmid
test
report
plasmid
frame
transform
select
hura
plate
day
coloni
transfer
ml
liquid
hura
medium
grown
overnight
shaker
cultur
dilut
hura
medium
without
anisomycin
mix
aliquot
place
plate
assay
present
report
repres
six
replic
per
plate
per
strain
outer
well
plate
contain
sampl
fill
instead
water
evenli
account
evapor
condens
rate
among
sampl
well
plate
cover
lid
seal
parafilm
incub
synergi
ht
micropl
reader
h
without
shake
cell
densiti
monitor
absorb
nm
everi
min
period
h
simultan
green
excit
nm
emiss
nm
red
excit
nm
emiss
nm
fluoresc
read
taken
prf
fs
calcul
follow
g
green
fluoresc
yeast
transform
test
control
vector
gev
green
fluoresc
yeast
transform
empti
vector
r
red
fluoresc
yeast
transform
test
control
vector
rev
red
fluoresc
yeast
transform
empti
vector
od
optic
densiti
cell
transform
report
plasmid
odev
optic
densiti
cell
transform
empti
vector
yeast
transform
renillafirefli
dual
luciferas
control
test
plasmid
la
frame
control
la
prf
tester
hiv
frame
control
hiv
prf
tester
yeast
plate
onto
select
media
day
transfer
ml
select
media
without
anisomycin
cell
incub
overnight
shaker
till
midlogarithm
growth
yeast
wash
three
time
lyse
pb
plu
mm
pmsf
use
mm
glass
bead
bead
beater
follow
centrifug
clarifi
lysat
strain
measur
seven
time
report
sequenti
mix
lysat
promega
larii
reagent
follow
stop
glo
dual
luciferas
reagent
quantifi
step
use
plateread
turner
biosystem
modulu
micropl
luminomet
assay
prf
statist
analys
perform
previous
describ
dual
luciferas
report
excel
monitor
prf
small
number
sampl
three
reason
particularli
amen
ht
applic
first
cost
sampl
cost
approxim
test
control
second
labor
time
intens
cell
lyse
clear
lysat
spectrophotometr
read
normal
protein
content
two
set
reagent
sequenti
introduc
lysat
read
limit
mind
develop
dualfluoresc
prf
assay
system
use
live
yeast
cell
control
report
monomer
dsred
egfp
frame
provid
baselin
data
figur
frameshift
report
plasmid
egfp
product
depend
prf
dsred
serv
intern
control
figur
figur
show
high
level
dsred
egfp
express
use
vector
figur
show
timecours
experi
monitor
promot
prf
monitor
everi
min
total
h
presenc
pink
trace
absenc
blue
trace
anisomycin
drug
inhibit
prf
note
signal
extrem
noisi
first
h
like
due
combin
two
factor
low
cell
densiti
timedepend
requir
two
report
protein
matur
especi
lowoxygen
environ
assay
protein
matur
densiti
increas
frameshift
effici
began
becom
discern
tend
stabil
h
endpoint
promot
prf
effici
untreat
cell
level
valu
compar
prf
measur
use
dual
luciferas
report
yeast
cell
notabl
assay
also
abl
recapitul
inhibitori
effect
anisomycin
promot
prf
timepoint
figur
show
plot
effect
anisomycin
prf
fold
wildtyp
level
demonstr
drug
inhibit
prf
consist
previou
find
next
test
abil
system
identifi
chang
prf
encod
yeast
la
viru
prf
signal
due
either
presenc
anisomycin
consequ
cellular
mutat
known
affect
prf
specif
anisomycin
yeast
mutant
expect
promot
decreas
rate
prf
mutant
expect
promot
increas
prf
mhj
rhodin
jd
dinman
unpublish
data
figur
show
plot
prf
fold
wildtyp
monitor
everi
min
h
system
noisi
first
h
began
stabil
h
take
h
endpoint
figur
show
system
produc
expect
result
specif
anisomycin
inhibit
data
duplic
figur
lamedi
prf
lamedi
prf
decreas
mutant
increas
strain
experi
repeat
use
previous
describ
dual
luciferas
assay
system
compar
result
obtain
use
dual
fluoresc
report
system
side
side
comparison
shown
figur
demonstr
strong
agreement
two
assay
system
result
match
previou
find
condit
anisomycin
inhibit
prf
promot
increas
prf
promot
decreas
prf
independ
valid
underscor
potenti
less
expens
scalabl
dual
fluoresc
methodolog
accur
detect
chang
frameshift
find
describ
demonstr
product
robust
inexpens
assay
faith
reproduc
chang
prf
due
cellular
mutat
addit
drug
advantag
use
multipl
well
format
enabl
data
collect
reader
directli
transfer
excel
spreadsheet
prf
rate
automat
calcul
importantli
softwar
also
determin
standard
error
flag
sampl
statist
signific
zscore
render
ideal
ht
applic
featur
inher
calcul
prf
effici
use
yeastbas
vivo
dualfluoresc
assay
also
two
critic
built
advantag
respect
counter
screen
first
sinc
assay
requir
normal
cell
densiti
measur
paramet
use
monitor
effect
compound
cell
growth
flag
potenti
cell
toxic
second
sinc
requir
normal
infram
control
measur
use
identifi
deleteri
effect
overal
protein
synthesi
monitor
prf
la
frameshift
signal
modular
natur
report
vector
render
insert
prf
signal
human
pathogen
virus
eg
htlvi
retroviru
famili
sarscov
coronaviru
famili
semliki
forest
viru
alphaviru
famili
sequenc
flavirus
japanes
enceph
viru
eastern
equin
enceph
viru
west
nile
viru
quit
simpl
other
empir
determin
even
small
chang
prf
strongli
deleteri
effect
viru
propag
review
suggest
initi
cutoff
set
wild
type
liber
cutoff
valu
allow
higher
rate
fals
posit
rather
fals
neg
thu
allow
fals
posit
identifi
later
secondari
assay
addit
basic
format
amen
assay
translat
recod
mechan
exampl
prf
termin
codon
suppress
candid
identifi
use
platform
secondari
assay
requir
valid
hit
suggest
two
assay
mainten
yeast
killer
viru
shown
mainten
viru
critic
depend
prf
extens
use
properti
valid
chang
prf
due
cellular
mutat
drug
importantli
assay
provid
independ
mean
screen
antivir
effect
compound
correl
effect
due
chang
prf
killer
assay
involv
replicapl
test
cell
onto
lawn
uninfect
indic
yeast
cell
seed
onto
mb
plate
yeast
rich
medium
contain
methylen
blue
ph
cell
grown
day
visual
inspect
presenc
zone
growth
inhibit
due
product
virusencod
killer
toxin
assay
simpl
inexpens
requir
yeast
cell
media
petri
dish
current
dual
fluoresc
assay
screen
sampl
per
plate
forgo
multipl
replic
assum
initi
identif
compound
assay
could
perform
plate
control
includ
killer
assay
either
perform
manual
case
hit
scale
highthroughput
robot
screen
believ
robot
technolog
current
use
highthroughput
yeast
screen
adapt
killer
assay
potenti
disadvantag
assay
may
requir
serial
passag
yeast
cell
multipl
round
drug
exposur
exampl
found
cure
killer
anisomycin
requir
least
two
serial
passag
presenc
drug
loss
killer
viru
valid
extract
total
rna
cell
follow
nondenatur
agaros
gel
electrophoresi
detect
presenc
absenc
viral
dsrna
genom
ii
dual
luciferas
assay
order
valid
potenti
hit
prf
valu
determin
use
vivo
live
yeast
cell
hela
cell
vitro
rabbit
reticulocyt
lysat
dualluciferas
assay
previous
describ
use
confirm
prf
data
obtain
use
dualfluoresc
report
dualluminesc
assay
secondari
assay
also
advantag
enabl
identif
compound
truli
affect
prf
oppos
affect
product
activ
dsred
egfp
report
protein
advantag
vitro
assay
identifi
compound
directli
affect
prf
oppos
compound
affect
transcript
report
mrna
number
paramet
remain
refin
one
autom
specif
plate
seed
industri
set
easili
address
use
robot
pipettor
robot
pipet
also
solv
problem
interfer
od
fluoresc
read
due
presenc
condens
plate
lid
end
incub
period
robot
transfer
cell
new
plate
prior
read
solv
problem
data
integr
anoth
problem
address
autom
coupl
plate
barcod
also
assur
worklist
download
robot
integr
data
also
organ
queryabl
format
howev
softwar
develop
flag
statist
signific
zscore
address
issu
also
address
issu
oper
bia
process
bottleneck
also
common
problem
ht
case
major
bottleneck
time
requir
matur
report
protein
henc
decis
take
h
endpoint
howev
growth
condit
may
optimiz
incub
humid
oxygen
environ
potenti
reduc
time
requir
signal
stabil
addit
parallel
process
multipl
plate
speed
process
render
bottleneck
insignific
ht
plate
must
contain
intern
control
suggest
mutant
cell
mutant
cell
sampl
contain
anisomycin
use
qualiti
control
downframeshift
respect
pool
also
commonli
use
ht
although
idea
attract
experi
lead
mistak
would
recommend
approach
cell
wall
permeabl
common
issu
associ
yeastbas
ht
yeast
cell
wall
imperm
mani
small
molecul
howev
yeast
cell
easili
toler
dmso
concentr
thu
reagent
could
use
rectifi
potenti
problem
final
ht
technolog
util
well
plate
thu
question
abil
scale
assay
howev
priori
reason
scale
well
work
although
possibl
scalingup
higher
densiti
format
may
present
issu
oxygen
transfer
need
support
cell
growth
vivo
assay
assum
oxygen
limit
problem
incub
could
easili
design
increas
ambient
oxygen
content
thu
mitig
problem
fund
open
access
charg
nation
institut
health
grant
jdd
conflict
interest
statement
preliminari
disclosur
document
file
univers
maryland
univers
delawar
pursuit
patent
applic
assay
system
